Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
15 April 2019 - P1860
In vitro activity of cefiderocol against extensively drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from the UK
Shazad Mushtaq, Zahra Sadouki, Anna Vickers, David Livermore, Neil Woodford
15 April 2019 - P1849
In vitro activities of gepotidacin, a novel triazaacenaphthylene topoisomerase IV and DNA gyrase inhibitor, against Gram-negative bacteria and Staphylococcus saprophyticus
Shazad Mushtaq, Anna Vickers, Zahra Sadouki, Michelle Cole, Helen Fifer, Vivienne DoNascimento, Martin Day, Elizabeth De Pinna, Claire Jenkins, Gauri Godbole, Neil Woodford
23 April 2018 - P1536
Potentiation of cefepime by the boronate VNRX-5133 versus Gram-negative bacteria with known beta-lactamases
Malcolm Richardson, S. Mushtaq, A. Vickers, N. Woodford, D. Livermore
22 April 2018 - P1033
Nacubactam (RG6080) alone and in combination against metallo-beta-lactamase (MBL)-producing Enterobacteriaceae
Barbara Juliane Holzknecht, S. Mushtaq, A. Vickers, N. Woodford, D. Livermore
22 April 2018 - P0763
Longitudinal comparative metagenomics of gut microbiome following ridiniazole versus fidaxomicin treatment of Clostridium difficile infection
Suparna Mitra, S. Mitra, J. Freeman, C. Chilton, M. Taylor, P. Quirke, H. Wood, R. Vickers, M. Wilcox
25 April 2017 - P2049
Ridinilazole treatment for C. difficile infection preserves the intestinal microbiota of patients
Taeeun Kim, Cheleste Thorpe, Anne Kane, Justin Chang, Richard Vickers, David R. Snydman
24 April 2017 - P1315
In-vitro activity of cefiderocol (S-649266) against multidrug-resistant Enterobacteriaceae from the UK
Shazad Mushtaq, Anna Vickers, Aasia Hussain, David Livermore, Neil Woodford
23 April 2017 - EP0399
Activity of novel pyrrolocytosine protein synthesis inhibitors against multi-resistant Gram-negative bacteria, including carbapenemase producers and those with MCR-1
David Livermore, Anna Vickers, Shazad Mushtaq, Neil Woodford
23 April 2017 - EP0404
Transcriptome functional analysis of Clostridium difficile exposed to ridinilazole-insight into potential mechanism of action
Lufang Zhang, Eugenie Basseres, Endres Bradley, Richard Vickers, M. Jahangir Alam, Khurshida Begum, Kevin Garey
23 April 2017 - OS0337
Should we start vaccinating adults with pneumococcal conjugate vaccines?
Mary Corcoran, Imelda Vickers, Martha McElligott, Jolita Mereckiene, Stephen Murchan, Suzanne Cotter, Margaret Fitzgerald, Mary Cafferkey, Robert Cunney, Hilary Humphreys
11 April 2016 - P1342
Understanding the mechanism of action for SMT19969, a novel treatment for Clostridium difficile
Lufang Zhang, Basseres Eugenie, Mishra Nagendra, E. Basseres, B. Endres, K. Mohammed, F. Miraftabi, M. Alam, R. Vickers, K. Garey
11 April 2016 - EP0177
Ridinilazole for Clostridium difficile infections: safety and efficacy compared with vancomycin from the CoDIFy phase 2 clinical trial
Mark H. Wilcox, Wilcox Mark H., Slobodnikova Livia, R. Vickers, G. Tillotson, R. Nathan, C. Lucasti, J. Pullman, S. Hazan, K. Deck, B. Maliakkal, Y. Pesant, B. Yacyshyn, D. Gerding, M. Wilcox
09 April 2016 - EV0428
Characterization of random Clostridium difficile mutants less susceptible to ridinilazole (SMT19969) in terms of fitness cost
Patrick Budd, Budd Patrick, D'Abramo Alessandra, P. Budd, M. Kelly, R. Vickers, K. Winzer, N. Minton, S. Kuehne
27 April 2015 - P0776
Impact of media on in vitro susceptibility testing of SMT19969 (and metronidazole) against clinical isolates of Clostridium difficile
Joseph M. Blondeau, Blondeau, Joseph M. *; Shebelski, Shantelle; Vickers, Richard;
27 April 2015 - P0945
The effect of pneumococcal conjugate vaccines on invasive pneumococcal disease amongst children in Ireland, 2007-2014
Mary Corcoran, Vickers, Imelda; Corcoran, Mary *; McElligott, Martha; Mereckiene, Jolita; Fitzgerald, Margaret; Murchan, Stephen; Cotter, Suzanne; Cafferkey, Mary; O'Flanagan, Darina; Cunney, Robert; Humphreys, Hilary;
25 April 2015 - P0241
Comparing the effects of SMT19969, vancomycin and fidaxomicin on sporulation of several Clostridium difficile ribotypes
Richard Vickers, Kelly, Michelle; Vickers, Richard*; Winzer, Klaus; Minton, Nigel; Kuehne, Sarah;
25 April 2015 - P0188
Surveillance of invasive pneumococcal disease and antimicrobial resistance in the adult population in Ireland from 2007 - 2014
Mary Corcoran, Vickers, Imelda; Corcoran, Mary *; McElligott, Martha; Mereckiene, Jolita; Fitzgerald, Margaret; Murchan, Stephen; Cotter, Suzanne; Cafferkey, Mary; O'Flanagan, Darina; Robert, Cunney; Humphreys, Hilary;
13 May 2014 - P1487
Community staphylococcal pyogenic skin infections in England: PVL, MRSA & clonal diversity
Per Espen Akselsen, Kearns, A.(1)*; Vickers, A.(1); Pichon, B.(1); Ganner, M.(1); Johnson, A.(2); Charlett, A.(3); Hill, R.(4);
11 May 2014 - P0798
SMT 19969 for Clostridium difficile infection (CDI): comparative efficacy compared to fidaxomicin and vancomycin in the hamster model of CDI
Richard Vickers, Vickers, R.(1)*; Teague, J.(2); Thomas, P.(2); Warn, P.A.(2);
11 May 2014 - P0801
SMT 19969: a novel agent for Clostridium difficile infection - summary results from in vitro microbiology and a randomised double blind phase 1 clinical trial
Richard Vickers, Vickers, R. J.(1)*; Citron, D.M.(2); Goldstein, E.J.C.(2); Best, E. L.(3); Wilcox, M.H.(3);
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.